Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22670 | 24373781 | J Am Acad Dermatol | Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. | 2013 | Details |
| A22673 | 24372862 | Hepatol Res | Upper limit of normal serum alanine aminotransferase levels in Japanese subjects. | 2014 | Details |
| A22677 | 27335843 | ISRN Hepatol | The Wide and Complex Field of NAFLD Biomarker Research: Trends. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22707 | 24366230 | Curr Opin Lipidol | Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. | 2014 | Details |
| A22721 | 24358044 | Hepat Mon | The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. | 2013 | Details |
| A22808 | 26355775 | J Clin Transl Hepatol | Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. | 2013 | Details |
| A22819 | 24287794 | Endocrine | Non-alcoholic fatty liver disease: a diabetologist's perspective. | 2013 | Details |
| A22829 | 24277052 | J Gastroenterol | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. | 2013 | Details |
| A22845 | 24274867 | Clin Liver Dis | The role of diet and nutritional intervention for the management of patients with NAFLD. | 2013 | Details |
| A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
| A22854 | 24251709 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22865 | 24267865 | Liver Int | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. | 2013 | Details |
| A22867 | 24266914 | Med Clin North Am | Review of treatment options for nonalcoholic fatty liver disease. | 2013 | Details |
| A22874 | 24262589 | Clin Nutr | Diets and nonalcoholic fatty liver disease: the good and the bad. | 2013 | Details |
| A22889 | 24250305 | Afr Health Sci | Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. | 2013 | Details |
| A22891 | 24249635 | FASEB J | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2013 | Details |
| A22915 | 24215040 | Scott Med J | An epidemiological study of the association of coffee with chronic liver disease. | 2013 | Details |
| A22917 | 24213605 | Int J Mol Sci | Environmental pollution: a tangible risk for NAFLD pathogenesis. | 2013 | Details |
| A22925 | 24206433 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. | 2013 | Details |
| A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A23010 | 24118857 | Liver Int | Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. | 2013 | Details |
| A23027 | 24099735 | J Public Health (Oxf) | The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients. | 2013 | Details |
| A23042 | 24083161 | Indian J Endocrinol Metab | Emerging risk factors for cardiovascular diseases: Indian context. | 2013 | Details |
| A23043 | 24081374 | Clin Drug Investig | Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose. | 2014 | Details |
| A23046 | 24080367 | Endocrinology | Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. | 2013 | Details |
| A23057 | 28839736 | Frontline Gastroenterol | Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience. | 2013 | Details |
| A23067 | 24068459 | Eur J Pediatr | Pediatric non-alcoholic fatty liver disease: an increasing public health issue. | 2013 | Details |
| A23101 | 24040873 | Curr Pharm Des | The role of oral antidiabetic agents and incretin mimetics in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A23112 | 24033085 | Eur J Clin Invest | Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. | 2013 | Details |
| A23135 | 24011648 | Gastroenterol Hepatol | [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. | 2013 | Details |
| A23159 | 23997062 | Eur Respir Rev | Sleep apnoea and metabolic dysfunction. | 2013 | Details |
| A23187 | 23976771 | JPEN J Parenter Enteral Nutr | The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23188 | 23975682 | Cochrane Database Syst Rev | Herbal medicines for fatty liver diseases. | 2013 | Details |
| A23231 | 23935723 | Exp Ther Med | Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. | 2013 | Details |
| A23248 | 23928114 | J Appl Physiol (1985) | Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. | 2013 | Details |
| A23255 | 23923077 | Int J Clin Exp Pathol | Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. | 2013 | Details |
| A23264 | 23917437 | Nutr Clin Pract | Pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
| A23280 | 23900558 | Dig Dis Sci | Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population. | 2013 | Details |
| A23282 | 23899279 | Expert Rev Gastroenterol Hepatol | Interaction of type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
| A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
| A23346 | 23853345 | Orv Hetil | [Non-alcoholic fatty liver disease and steatohepatitis]. | 2013 | Details |
| A23399 | 23814606 | Therap Adv Gastroenterol | Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. | 2013 | Details |
| A23417 | 23801829 | World J Gastroenterol | What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? | 2013 | Details |
| A23427 | 23793849 | Curr Hypertens Rep | Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review. | 2013 | Details |
| A23447 | 23772273 | World J Diabetes | Gastrointestinal complications of diabetes mellitus. | 2013 | Details |
| A23465 | 23756665 | Korean J Gastroenterol | [The role of diet in non-alcoholic fatty liver disease]. | 2013 | Details |
| A23493 | 23731053 | J Gastroenterol Hepatol | Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China. | 2013 | Details |
| A23499 | 23721476 | Hepatol Res | Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23546 | 23692373 | Diabet Med | Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. | 2013 | Details |
| A23582 | 23657989 | Intern Emerg Med | Physical activity for the prevention and treatment of metabolic disorders. | 2013 | Details |
| A23619 | 23623998 | J Hepatol | Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. | 2013 | Details |
| A23621 | 23622654 | Transplant Proc | Recurrence of disease after liver transplantation. | 2013 | Details |
| A23673 | 23577962 | J Gastroenterol Hepatol | Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. | 2013 | Details |
| A23674 | 23576902 | ScientificWorldJournal | Current concepts and management approaches in nonalcoholic fatty liver disease. | 2013 | Details |
| A23685 | 23565376 | Indian J Endocrinol Metab | Childhood obesity: Determinants, evaluation, and prevention. | 2012 | Details |
| A23696 | 23558065 | Hepatobiliary Pancreat Dis Int | Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. | 2013 | Details |
| A23714 | 23545492 | Genomics | Genomic aspects of NAFLD pathogenesis. | 2013 | Details |
| A23745 | 23514731 | Diabetes Care | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. | 2013 | Details |
| A23748 | 23512725 | Obesity (Silver Spring) | Racial differences in nonalcoholic fatty liver disease in the U.S. population. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
| A23764 | 23504808 | Hepatology | Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? | 2013 | Details |
| A23773 | 23493072 | Curr Opin Gastroenterol | Paediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
| A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
| A23825 | 26064833 | J Lifestyle Med | Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. | 2013 | Details |
| A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
| A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
| A23880 | 23406154 | Lipids Health Dis | Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice. | 2013 | Details |
| A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
| A23897 | 23397532 | Semin Liver Dis | A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease. | 2013 | Details |
| A23905 | 23394095 | Curr Pharm Des | The role of lifestyle change in the prevention and treatment of NAFLD. | 2013 | Details |
| A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23948 | 23359475 | Pharmacotherapy | Pharmacologic therapy for nonalcoholic fatty liver disease in adults. | 2013 | Details |
| A23953 | 23355909 | World J Hepatol | Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. | 2012 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A24056 | 23273500 | Clin Res Hepatol Gastroenterol | Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24085 | 23239917 | World J Gastroenterol | Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? | 2012 | Details |
| A24087 | 23238106 | J Hepatol | A 360-degree overview of paediatric NAFLD: recent insights. | 2012 | Details |
| A24126 | 23205728 | Free Radic Res | Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E. | 2013 | Details |
| A24129 | 23201248 | J Hepatol | Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. | 2012 | Details |
| A24130 | 23198569 | Nihon Rinsho | [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis]. | 2012 | Details |
| A24157 | 23174203 | Proc Nutr Soc | The gut microbial metabolome: modulation of cancer risk in obese individuals. | 2012 | Details |
| A24236 | 23090329 | Nat Rev Gastroenterol Hepatol | Physical activity: an essential component of lifestyle modification in NAFLD. | 2012 | Details |
| A24245 | 23081825 | Hepatology | Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. | 2013 | Details |
| A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
| A24300 | 23026517 | Biomed Environ Sci | The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. | 2012 | Details |
| A24310 | 23018041 | Nutr Metab Cardiovasc Dis | Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24312 | 23012671 | J Gastrointestin Liver Dis | Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? | 2012 | Details |
| A24318 | 23001964 | Pediatr Obes | The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? | 2012 | Details |
| A24320 | 23000278 | Appetite | Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. | 2012 | Details |
| A24334 | 22989165 | J Gastroenterol Hepatol | Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. | 2013 | Details |
| A24369 | 22963909 | Dig Liver Dis | Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. | 2012 | Details |
| A24447 | 22884299 | Clin Res Hepatol Gastroenterol | PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function? | 2012 | Details |
| A24476 | 22855698 | World J Hepatol | Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China. | 2012 | Details |